Peptides researched for
Chronic hepatitis B
1 peptide · 2 studies
What people research this for
People living with chronic hepatitis B want to keep the virus under control and protect their liver. One immune peptide, thymosin alpha-1, was tested for this years ago. Antiviral medicines are the standard treatment today.
Researched for
- Chronic hepatitis B
- The immune response to the virus
What the studies say so far
Thymosin alpha-1 was tested in hepatitis B trials before today's antivirals were in use. A 2018 review went back over those older trials and argued that combining it with modern antivirals may be worth studying again. That is a call for more research. Results from the older trials were mixed, and the peptide is not a cure on its own.
Peptides studied
Each peptide below has been studied in this area. The label shows how far that research has gone.
Thymosin Alpha-1
Mixed resultsResearch review · 2 studies
Study note. Historical thymosin α1 HBV immunotherapy trials are reassessed for possible combination strategies in the antiviral era.
- Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach. (opens in a new tab)
Naylor PH, Mutchnick MG · Journal of viral hepatitis · 2018 · PubMed
- Thymosin alpha 1: A comprehensive review of the literature (opens in a new tab)
Dominari A, Hathaway III D, Pandav K · World J Virol · 2020 · PubMed
- Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach. (opens in a new tab)
Look this up in the PeptIQ app
The app has the same research and sources, next to the tools you use to track your own protocol.
